Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI150334
Fogarty International Center of the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health
Grant: FIC D43TW010540 and T32AR007107
NIAMS NIH HHS
Grant: T32 AR007107
FIC NIH HHS
Grant: D43 TW010540
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 1R01AI150334-01
Mechanisms of transcriptional regulation of ccr5 and host genetic control of HIV
National Institutes of Health
Grant: 3D43TW010540-04S1
Global Health Equity Scholars Program - D43 Fogarty Training
National Institutes of Health
Grant: 5T32AR007107-40
Training Program in Investigative Rheumatology
National Institute of Allergy and Infectious Diseases
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals